Learning Objectives:

1. To learn the new nomenclature for NAFLD and NASH.

2. To understand the optimal care pathway for patients with NAFLD/MASLD.

3.  To be aware of current management options and emerging therapies.

Session date: 
11/21/2023 - 4:30pm to 5:30pm CST
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Dr. Mary Rinella